Arsène Zongo
Professeur agrégé
Pharmacie-Direction
Pavillon Ferdinand-Vandry
- Centre de recherche du CHU de Québec - Université Laval
- Centre de recherche du CHU de Québec - Université Laval
Assessing the protective effect of dutasteride on Parkinson’s disease: a real-world study following preclinical assessment
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2026 au 31 mars 2030
Silent Battles: Exploring the Diverse Experiences of Canadian Veterans Living with Chronic Pain
Programme: Évaluer et améliorer la qualité de vie des vétérans canadiens vivant avec de la douleur chronique et des comorbidités courantes
Organisme(s) subventionnaire(s): Centre d'excellence pour la douleur chronique pour les vétérans canadiens
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 février 2025 au 31 janvier 2027
Usage récréatif du cannabis et méfaits liés au cannabis: Connaissances provenant d'une trajectoire de soins communautaires vers les cliniques de cannabis
Programme: Actions concertées Programme de recherche sur l'usage du cannabis à des fins non-médicales : réduction et prévention des méfaits
Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Société et culture
Type de financement: Subvention
Établissement tête: Université McGill
Du 1 juillet 2022 au 1 octobre 2024
Traduction et adaptation culturelle pour le Québec d’un questionnaire mesurant l’usage médical du cannabis
Programme: Réseaux thématiques de recherche
Organisme(s) subventionnaire(s): Fonds de recherche du Québec - Santé
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2022 au 30 octobre 2024
- Jihane El Mourad, Doctorat en sciences pharmaceutiques - pharmaco-épidémiologie
- Arvis Abraham Sebgo, Maîtrise en sciences pharmaceutiques - pharmaco-épidémiologie - avec mémoire
- Bassirou Diouf, Maîtrise en épidémiologie - avec mémoire
Encadrements terminés dans les 5 dernières années
- Zoumana Cheick Bérété, Maîtrise en sciences pharmaceutiques - pharmaco-épidémiologie - avec mémoire
- Jihane El Mourad, Maîtrise en sciences pharmaceutiques - pharmaco-épidémiologie - avec mémoire
- Amélie Bélanger, Maîtrise en sciences pharmaceutiques - avec mémoire
- Jerry Liwono Yana, Maîtrise en sciences pharmaceutiques - pharmaco-épidémiologie - avec mémoire
Publications des 5 dernières années
Risk of Heart Failure-related Events in Patients Exposed to Medical Cannabis: A Longitudinal Cohort Study, American Journal of Medicine Open, 2026. Cerina Dubois, Dean T. Eurich, Jason R.B. Dyck, Elaine Hyshka, John G. Hanlon, Arsene Zongo. DOI 10.1016/j.ajmo.2025.100120
Opioid Initiation in Older Patients with Chronic Pain Who Received Authorized Cannabis Prescription, Substance Use & Misuse, 2026. Emilie Fontaine, Jihane El-Mourad, Cerina Dubois, Dean T. Eurich, Jason R. B. Dyck, John G. Hanlon, Arsene Zongo. DOI 10.1080/10826084.2025.2586250
Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study, Age and Ageing, 2025. Zoumana Cheick Bérété, Arvis Abraham Sebgo, Dean T Eurich, Cerina Dubois, Jason R Dyck, John G Hanlon, Arsene Zongo. DOI 10.1093/ageing/afaf359
Reliability of a self-reported questionnaire assessing the use of cannabis products to treat chronic pain 2025. Edeltraut Kröger, Clermont E. Dionne, Zoumana Cheick Bérété, Malek Amiri, Anaïs Lacasse, Arsène Zongo. DOI 10.21203/rs.3.rs-8050715/v1
Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France, Fundamental & Clinical Pharmacology, 2025. Marie‐Laure Laroche, Marion Labetoulle, Emilie Jouanjus, Edeltraut Kröger, Arsène Zongo. DOI 10.1111/fcp.70028
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies, Pain Management Nursing, 2024. Jihane El-Mourad, Carlotta Lunghi, Norma Perez Herrera, Arsène Zongo. DOI 10.1016/j.pmn.2023.08.005
Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries, Pharmaceutical Medicine, 2023. Kampadilemba Ouoba, Hélène Lehmann, Arsène Zongo, Jean-Yves Pabst, Rasmané Semdé. DOI 10.1007/s40290-023-00478-8
Phytopharmaceutical practices of traditional health practitioners in Burkina Faso: a cross-sectional study, BMC Complementary Medicine and Therapies, 2023. Kampadilemba Ouoba, Hélène Lehmann, Arsène Zongo, Rasmané Semdé, Jean-Yves Pabst. DOI 10.1186/s12906-023-04055-z
Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study, Psychiatry Research, 2023. Jerry Liwono Yana, Cerina Lee, Dean T. Eurich, Jason R.B. Dyck, John G. Hanlon, Arsène Zongo. DOI 10.1016/j.psychres.2022.115047
A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada, Journal of Cannabis Research, 2022. Antoine Asselin, Olivier Beauparlant Lamarre, Richard Chamberland, Sarah-Jeanne McNeil, Eric Demers, Arsène Zongo. DOI 10.1186/s42238-022-00135-y
Compliance to the legal and ethical requirements for the practice of traditional medicine: a cross-sectional study among traditional health practitioners in Burkina Faso, European Journal of Integrative Medicine, 2022. Kampadilemba Ouoba, Hélène Lehmann, Arsène Zongo, Antoine Serge Guillaume Amari, Rasmané Semdé, Jean-Yves Pabst. DOI 10.1016/j.eujim.2022.102189
Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study., Substance use & misuse, 2022. Arsene Zongo. , DOI 10.1080/10826084.2022.2102193
Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus., Diabetic medicine : a journal of the British Diabetic Association, 2022. Arsene Zongo. , DOI 10.1111/dme.14858
Prevalence of traditional medicines use and adverse events: A population-based cross-sectional survey in Burkina Faso, European Journal of Integrative Medicine, 2022. Arsene Zongo. DOI 10.1016/j.eujim.2022.102129
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment., Diabetes & metabolism, 2022. Arsene Zongo. , DOI 10.1016/j.diabet.2022.101334
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study., Canadian journal of diabetes, 2021. Arsene Zongo. , DOI 10.1016/j.jcjd.2021.12.005
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study. , BMJ open diabetes research & care, 2021. Arsene Zongo. , DOI 10.1136/bmjdrc-2021-002496
Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study., Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2021. Arsene Zongo. , DOI 10.1177/07067437211060597
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs., Diabetes & metabolism, 2021. Arsene Zongo. , DOI 10.1016/j.diabet.2021.101305
Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study., BMC cardiovascular disorders, 2021. Arsene Zongo. , DOI 10.1186/s12872-021-02229-6
A description of self-medication with cannabis among adults with legal access to cannabis 2021. Antoine Asselin, Olivier Beauparlant Lamarre, Richard Chamberland, Sarah-Jeanne Mc Neil, Éric Demers, Arsene Zongo. DOI 10.21203/rs.3.rs-528768/v1
Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension., Journal of managed care & specialty pharmacy, 2021. Arsene Zongo.